World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
54
Citations
15280
World Ranking
4849
National Ranking
2183

Best Publications

  • The scientific and clinical basis for the treatment of Parkinson disease (2009)

    C. Warren Olanow;Matthew B. Stern;Kapil Sethi

  • The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

    Kallol Ray Chaudhuri;Pablo Martinez-Martin;Richard G. Brown;Kapil Sethi

  • SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

    Irene Litvan;Kailash P. Bhatia;David J. Burn;Christopher G. Goetz

  • Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

    Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi;Kapil Sethi

  • The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire

    K. Ray Chaudhuri;Cristina Prieto-Jurcynska;Yogini Naidu;Tanya Mitra

  • The role of radiotracer imaging in Parkinson disease

    B. Ravina;D. Eidelberg;J. E. Ahlskog;R. L. Albin

  • Ropinirole for the treatment of early Parkinson's disease

    C. H. Adler;K. D. Sethi;R. A. Hauser;T. L. Davis

  • A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit

    M Flint Beal;David Oakes;Ira Shoulson

  • Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study

    Arthur S Walters;William G Ondo;Tilman Dreykluft;Ron Grunstein

  • International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

    P. Martinez-Martin;C. Rodriguez-Blazquez;K. Abe;K. B. Bhattacharyya;K. B. Bhattacharyya

  • Nonmotor Manifestations of Parkinson's Disease

    Tatyana Simuni;Kapil Sethi

  • A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

    M. F. Brin;K. E. Lyons;J. Doucette;C. H. Adler

  • Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

    Mark Stacy;Annette Bowron;Mark Guttman;Robert Hauser

  • A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease

    Abraham N. Lieberman;C. W. Olanow;K. Sethi;P. Swanson

  • Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.

    K. D. Sethi;R. J. Adams;D. W. Loring;T. El Gammal

  • Reliability of a new scale for essential tremor

    Rodger Elble;Cynthia Comella;Stanley Fahn;Mark Hallett

  • Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

    Robert A. Hauser;Ann Hsu;Sherron Kell;Alberto J. Espay

  • Levodopa Unresponsive Symptoms in Parkinson Disease

    Kapil Sethi

  • Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.

    Cheryl H. Waters;Kapil D. Sethi;Robert A. Hauser;Eric Molho

  • Drug-induced tremors

    John Christopher Morgan;John Christopher Morgan;Kapil D. Sethi

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles